Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed an approximately $15 million Series A round for GT Metabolic Solutions, which has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery. The company will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.

Wesper, previously known as Tatch, is a state-of-the-art diagnostic and outcome management patch, that provides high-quality sleep analysis in maximal comfort. Wesper brings together advances in printed electronics, machine learning and wearable technology to make sleep medicine more seamless and accurate than ever before. 

Ceros Financial Services Arranges $15 Million Financing For Gt Metabolic Solutions

Description

Company Information

Related People

Funding Insights

Ceros Financial Services Arranges $15 Million Financing For Gt Metabolic Solutions

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information